Literature DB >> 23280542

Concomitant JAK2 V617F-positive polycythemia vera and B-cell chronic lymphocytic leukemia in three patients originating from two separate hematopoietic stem cells.

Sabina Swierczek, Jitka Nausova, Jaroslav Jelinek, Enli Liu, Paul Roda, Jana Kucerova, Marie Jarosova, Helena Urbankova, Karel Indrak, Josef T Prchal, Vladimir Divoky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23280542      PMCID： PMC3556177          DOI： 10.1002/ajh.23362

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  14 in total

1.  Evidence that the JAK2 G1849T (V617F) mutation occurs in a lymphomyeloid progenitor in polycythemia vera and idiopathic myelofibrosis.

Authors:  François Delhommeau; Sabrina Dupont; Carole Tonetti; Aline Massé; Isabelle Godin; Jean-Pierre Le Couedic; Najet Debili; Patrick Saulnier; Nicole Casadevall; William Vainchenker; Stéphane Giraudier
Journal:  Blood       Date:  2006-09-05       Impact factor: 22.113

2.  B-CLL developing in a patient with PV is not affected by V617F mutation of the Janus kinase 2.

Authors:  Kais Hussein; Kai Brakensiek; Matthias Ballmaier; Matthias Bormann; Gudrun Göhring; Thomas Buhr; Oliver Bock; Hans Kreipe
Journal:  Eur J Haematol       Date:  2006-12       Impact factor: 2.997

3.  Association of essential thrombocythemia and chronic lymphocytic leukemia: absence of the V617F JAK2 mutation in the lymphoid compartment.

Authors:  Laurent Henry; Serge Carillo; Eric Jourdan; Anne Arnaud; Sophie Brun; Thierry Lavabre-Bertrand
Journal:  Am J Hematol       Date:  2007-06       Impact factor: 10.047

4.  Polycythemia vera is not initiated by JAK2V617F mutation.

Authors:  Roberto H Nussenzveig; Sabina I Swierczek; Jaroslav Jelinek; Amos Gaikwad; Enli Liu; Srdan Verstovsek; Jaroslav F Prchal; Josef T Prchal
Journal:  Exp Hematol       Date:  2007-01       Impact factor: 3.084

5.  Spleens of myelofibrosis patients contain malignant hematopoietic stem cells.

Authors:  Xiaoli Wang; Sonam Prakash; Min Lu; Joseph Tripodi; Fei Ye; Vesna Najfeld; Yan Li; Myron Schwartz; Rona Weinberg; Paul Roda; Attilio Orazi; Ronald Hoffman
Journal:  J Clin Invest       Date:  2012-11       Impact factor: 14.808

Review 6.  Lessons from familial myeloproliferative disorders.

Authors:  Radek Skoda; Josef T Prchal
Journal:  Semin Hematol       Date:  2005-10       Impact factor: 3.851

7.  No evidence for JAK2(V617F) mutation in monoclonal B cells in 2 patients with polycythaemia vera and concurrent monoclonal B cell disorder.

Authors:  C Stijnis; W G M Kroes; S Balkassmi; E W A Marijt; A P van Rossum; E Bakker; L T Vlasveld
Journal:  Acta Haematol       Date:  2012-08-10       Impact factor: 2.195

8.  Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

Authors:  Robert Kralovics; Soon-Siong Teo; Sai Li; Alexandre Theocharides; Andreas S Buser; Andre Tichelli; Radek C Skoda
Journal:  Blood       Date:  2006-05-04       Impact factor: 22.113

9.  Polycythemia vera: stem-cell and probable clonal origin of the disease.

Authors:  J W Adamson; P J Fialkow; S Murphy; J F Prchal; L Steinmann
Journal:  N Engl J Med       Date:  1976-10-21       Impact factor: 91.245

Review 10.  The evolving contribution of hematopoietic progenitor cells to lymphomagenesis.

Authors:  Oliver Weigert; David M Weinstock
Journal:  Blood       Date:  2012-08-06       Impact factor: 22.113
View more
  5 in total

1.  Chronic lymphocytic leukemia and myeloproliferative neoplasms concurrently diagnosed: clinical and biological characteristics.

Authors:  Gabriele Todisco; Taghi Manshouri; Srdan Verstovsek; Lucia Masarova; Sherry A Pierce; Michael J Keating; Zeev Estrov
Journal:  Leuk Lymphoma       Date:  2015-10-19

2.  Acute Lymphoblastic Leukemia Arising in CALR Mutated Essential Thrombocythemia.

Authors:  Stephen E Langabeer; Karl Haslam; David O'Brien; Johanna Kelly; Claire Andrews; Ciara Ryan; Richard Flavin; Patrick J Hayden; Christopher L Bacon
Journal:  Case Rep Hematol       Date:  2016-01-21

3.  Expression of CD markers in JAK2V617F positive myeloproliferative neoplasms: Prognostic significance.

Authors:  Saeid Shahrabi; Ali Ehsanpour; Somayyeh Heidary; Mohammad Shahjahani; Masumeh Maleki Behzad
Journal:  Oncol Rev       Date:  2018-10-02

4.  JAK2 V617F detected in two B-cell chronic lymphocytic leukemia patients without coexisting Philadelphia chromosome-negative myeloproliferative neoplasms: A report of two cases.

Authors:  Yi-Ning Yang; You-Wen Qin; Chun Wang
Journal:  Oncol Lett       Date:  2014-05-22       Impact factor: 2.967

Review 5.  Coexistence of chronic lymphocytic leukemia and polycythemia vera: a case report and review of the literature.

Authors:  Serdal Korkmaz; Sinan Kulakoglu; Hasan Gorkem; Bilal Aygun; Ali Cetinkaya
Journal:  Ann Saudi Med       Date:  2016 Sep-Oct       Impact factor: 1.526
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.